Surgalign has announced that its HOLO Portal surgical guidance system has officially entered clinical use, with the first procedure performed at Indiana Spine Hospital (Carmel, USA) by Mario Brkaric, a board-certified orthopaedic surgeon.
According to Surgalign, the HOLO Portal system is the world’s first surgical guidance system incorporating artificial intelligence (AI) and augmented reality (AR) and the first clinical application of Surgalign’s HOLO AI digital health platform.
HOLO Portal’s convolutional neural networks process intraoperative images to autonomously identify patient anatomy and plan patient-specific pedicle screw trajectories approved by the surgeon. The system then displays the anatomy and pinpoints the trajectories for ease of placement, using the AR display, the company states in a press release.
In January 2022, Surgalign received US Food and Drug Administration (FDA) 510(k) clearance for the HOLO Portal system’s use within lumbar spine procedures. The company has now moved into its limited market release and intends to ramp up its site locations.
“HOLO Portal is a remarkably efficient technology in that its AI autonomously labels anatomy and proposes a surgical plan from intraoperative imaging. I then view the resulting guidance information in 3D through its holographic display. This helps ensure that every pedicle screw is precise in its size, trajectory, and placement,” said Brkaric. “That improvement in surgical precision can help lead to better patient outcomes and fewer complications. This is groundbreaking technology, and I expect that many more surgeons will adopt the HOLO Portal in our practice and across the country.”
Rick Sasso, founding member and president of the Indiana Spine Group, added: “Congratulations to Mario Brkaric for completing the first surgical case with the Surgalign HOLO Portal system. It’s great to see the physicians at Indiana Spine Group adopting new technologies and I look forward to adopting the HOLO AI technology into my practice to drive better patient outcomes.”
Terry Rich, president and CEO of Surgalign, commented: “It’s an absolute honour to work with Indiana Spine Hospital and Mario Brkaric on the first clinical adoption of our HOLO AI technology. This is truly a foundational step in our new digital phase as we launch the first of many planned AI technologies in our roadmap.”